Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients.

Kamboj M, Chung D, Seo SK, Pamer EG, Sepkowitz KA, Jakubowski AA, Papanicolaou G.

Biol Blood Marrow Transplant. 2010 Nov;16(11):1576-81. doi: 10.1016/j.bbmt.2010.05.008. Epub 2010 May 26.

2.

Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients.

Kang Y, Vicente M, Parsad S, Brielmeier B, Pisano J, Landon E, Pettit NN.

Transpl Infect Dis. 2013 Oct;15(5):466-73. doi: 10.1111/tid.12120. Epub 2013 Aug 4.

PMID:
23911080
3.

The clinical impact of vancomycin-resistant Enterococcus colonization and bloodstream infection in patients undergoing autologous transplantation.

Ford CD, Lopansri BK, Gazdik MA, Snow GL, Webb BJ, Konopa KL, Petersen FB.

Transpl Infect Dis. 2015 Oct;17(5):688-94. doi: 10.1111/tid.12433. Epub 2015 Oct 3.

PMID:
26256692
4.

Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation.

Vydra J, Shanley RM, George I, Ustun C, Smith AR, Weisdorf DJ, Young JA.

Clin Infect Dis. 2012 Sep;55(6):764-70. doi: 10.1093/cid/cis550. Epub 2012 Jun 12.

5.

Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant.

Weinstock DM, Conlon M, Iovino C, Aubrey T, Gudiol C, Riedel E, Young JW, Kiehn TE, Zuccotti G.

Biol Blood Marrow Transplant. 2007 May;13(5):615-21. Epub 2007 Mar 23.

6.

The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients.

Satlin MJ, Soave R, Racanelli AC, Shore TB, van Besien K, Jenkins SG, Walsh TJ.

Leuk Lymphoma. 2014 Dec;55(12):2858-65. doi: 10.3109/10428194.2014.896007. Epub 2014 Mar 24.

7.

Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course.

Avery R, Kalaycio M, Pohlman B, Sobecks R, Kuczkowski E, Andresen S, Mossad S, Shamp J, Curtis J, Kosar J, Sands K, Serafin M, Bolwell B.

Bone Marrow Transplant. 2005 Mar;35(5):497-9.

PMID:
15640812
8.

Empiric use of linezolid in febrile hematology and hematopoietic stem cell transplantation patients colonized with vancomycin-resistant Enterococcus spp.

Lisboa LF, Miranda BG, Vieira MB, Dulley FL, Fonseca GG, GuimarĂ£es T, Levin AS, Shikanai-Yasuda MA, Costa SF.

Int J Infect Dis. 2015 Apr;33:171-6. doi: 10.1016/j.ijid.2015.02.001. Epub 2015 Feb 7.

9.

Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation.

Tavadze M, Rybicki L, Mossad S, Avery R, Yurch M, Pohlman B, Duong H, Dean R, Hill B, Andresen S, Hanna R, Majhail N, Copelan E, Bolwell B, Kalaycio M, Sobecks R.

Bone Marrow Transplant. 2014 Oct;49(10):1310-6. doi: 10.1038/bmt.2014.150. Epub 2014 Aug 11.

PMID:
25111516
10.

Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation.

Kapur D, Dorsky D, Feingold JM, Bona RD, Edwards RL, Aslanzadeh J, Tutschka PJ, Bilgrami S.

Bone Marrow Transplant. 2000 Jan;25(2):147-52.

11.

Impact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients: a 12-year single institution study.

Seo SK, Xiao K, Huang YT, Jongwutiwes U, Chung D, Maloy M, Giralt S, Barker JN, Jakubowski AA, Papanicolaou GA.

J Infect. 2014 Oct;69(4):341-351. doi: 10.1016/j.jinf.2014.06.004. Epub 2014 Jun 12.

12.

Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients.

Mikulska M, Del Bono V, Prinapori R, Boni L, Raiola AM, Gualandi F, Van Lint MT, Dominietto A, Lamparelli T, Cappellano P, Bacigalupo A, Viscoli C.

Transpl Infect Dis. 2010 Dec;12(6):505-12. doi: 10.1111/j.1399-3062.2010.00544.x.

PMID:
20636482
13.

Incidence and clinical complications of vancomycin-resistant enterococcus in pediatric stem cell transplant patients.

Tsiatis AC, Manes B, Calder C, Billheimer D, Wilkerson KS, Frangoul H.

Bone Marrow Transplant. 2004 May;33(9):937-41.

PMID:
15034540
14.

Vancomycin-Resistant Enterococcus Colonization and Bacteremia and Hematopoietic Stem Cell Transplantation Outcomes.

Ford CD, Gazdik MA, Lopansri BK, Webb B, Mitchell B, Coombs J, Hoda D, Petersen FB.

Biol Blood Marrow Transplant. 2017 Feb;23(2):340-346. doi: 10.1016/j.bbmt.2016.11.017. Epub 2016 Nov 23.

PMID:
27890428
15.

Molecular epidemiology and risk factors for colonization by vancomycin-resistant Enterococcus in patients with hematologic malignancies.

Almyroudis NG, Lesse AJ, Hahn T, Samonis G, Hazamy PA, Wongkittiroch K, Wang ES, McCarthy PL Jr, Wetzler M, Segal BH.

Infect Control Hosp Epidemiol. 2011 May;32(5):490-6. doi: 10.1086/659408.

PMID:
21515980
16.

Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.

Blennow O, Ljungman P, Sparrelid E, Mattsson J, Remberger M.

Transpl Infect Dis. 2014 Feb;16(1):106-14. doi: 10.1111/tid.12175. Epub 2013 Dec 30.

PMID:
24372809
17.

Discontinuation of Systematic Surveillance and Contact Precautions for Vancomycin-Resistant Enterococcus (VRE) and Its Impact on the Incidence of VRE faecium Bacteremia in Patients with Hematologic Malignancies.

Almyroudis NG, Osawa R, Samonis G, Wetzler M, Wang ES, McCarthy PL, Segal BH.

Infect Control Hosp Epidemiol. 2016 Apr;37(4):398-403. doi: 10.1017/ice.2015.310. Epub 2016 Jan 11.

PMID:
26750087
18.

Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality.

Lautenbach E, Bilker WB, Brennan PJ.

Infect Control Hosp Epidemiol. 1999 May;20(5):318-23.

PMID:
10349947
20.

Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.

Kimura M, Araoka H, Yoshida A, Yamamoto H, Abe M, Okamoto Y, Yuasa M, Kaji D, Kageyama K, Nishida A, Ishiwata K, Takagi S, Yamamoto G, Asano-Mori Y, Uchida N, Hishinuma A, Izutsu K, Wake A, Taniguchi S, Yoneyama A.

BMC Infect Dis. 2016 Aug 5;16:372. doi: 10.1186/s12879-016-1692-y.

Supplemental Content

Support Center